# Xylem Stock: Analyst Estimates and Ratings Investment insights and analyst perspectives on Xylem stock. - **Source:** [Yahoo Finance](https://brifing.si/source/7f1dcdb9-78c9-4a6d-ac05-c0d4d417b569) - **Published:** 2026-08-18 - **Topic:** [Finance](https://brifing.si/c/finance) - **Original article:** - **On Brifing:** https://brifing.si/s/020d4293-278e-46d2-8867-1beaed738aa2 ## Key Facts About Xylem Xylem is a global leader in water technology solutions. The company provides water infrastructure, wastewater treatment and analytical solutions. It trades on NYSE under the ticker XYL. In 2023, Xylem reported $5.5 billion in revenue. Its product portfolio includes pumps, filtration systems and digital water management solutions serving utilities and industries worldwide. ## Latest Analyst Ratings Morgan Stanley upgraded Xylem to 'Overweight' with $120 price target. JP Morgan maintains 'Neutral' rating. Goldman Sachs set 12-month target at $115. Currently, 65% of analysts recommend 'Buy', 25% suggest 'Hold' while 10% advise 'Sell'. These ratings compare favorably to sector averages. The consensus indicates moderate upside potential from current levels. ## Financial Health Indicators Xylem's P/E ratio of 28.5 exceeds industry average. Last quarter EBITDA margin reached 18.7%. Free cash flow stood at $350 million. Revenue growth projection for 2024 is 6.5%. Debt-to-equity ratio of 0.45 reflects strong balance sheet. The company has consistently delivered above-average returns on invested capital in recent years. ## Competitive Position Xylem holds 12% global market share in water technologies. Main competitors include Ecolab and Pentair. Increasing sustainability investments support growth. The company committed to carbon neutrality by 2025. Growing water scarcity issues drive demand for Xylem's infrastructure and treatment solutions worldwide. ## Technical Analysis Outlook Xylem stock gained 15% over past 3 months. 50-day moving average stands at $105. RSI indicator at 58 suggests neutral position. Breaking $110 resistance could accelerate upward momentum. 200-day average provides support at $98 level. Trading volume patterns indicate steady institutional interest. ## Management Strategy Under CEO Patrick Decker, Xylem completed 3 strategic acquisitions in 5 years. The 2023 Evoqua purchase expanded wastewater capabilities. R&D spending remains steady at 4% of revenue. Digital transformation investments are prioritized. Management forecasts 5-7% revenue growth for 2024, citing infrastructure modernization trends. ## Key Risk Factors Global economic slowdown may impact water infrastructure spending. Rising material costs could pressure margins. Intensifying competition may limit pricing power. Regulatory changes might increase compliance costs. Stronger dollar could negatively affect international revenue conversion. Execution risks in integration of acquisitions remain. ## Investment Considerations Xylem appeals to long-term growth investors. Sustainability trends align with company's strategic focus. Majority analyst ratings remain positive. Short-term volatility expected but fundamentals appear solid. Increasing water stress globally enhances Xylem's positioning. The stock offers balanced risk-reward profile for patient investors. ## Sources covering this story - https://finance.yahoo.com/markets/stocks/articles/xylem-stock-analyst-estimates-ratings-095644774.html — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._